
Hunan Fangsheng Pharmaceutical Co Ltd
SSE:603998

Intrinsic Value
The intrinsic value of one
Hunan Fangsheng Pharmaceutical Co Ltd
stock under the Base Case scenario is
14.9
CNY.
Compared to the current market price of 10.19 CNY,
Hunan Fangsheng Pharmaceutical Co Ltd
is
Undervalued by 32%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Hunan Fangsheng Pharmaceutical Co Ltd
Fundamental Analysis



Revenue & Expenses Breakdown
Hunan Fangsheng Pharmaceutical Co Ltd
Balance Sheet Decomposition
Hunan Fangsheng Pharmaceutical Co Ltd
Current Assets | 1B |
Cash & Short-Term Investments | 197.3m |
Receivables | 336.1m |
Other Current Assets | 496.5m |
Non-Current Assets | 2.2B |
Long-Term Investments | 257.8m |
PP&E | 1.1B |
Intangibles | 533.2m |
Other Non-Current Assets | 256.6m |
Free Cash Flow Analysis
Hunan Fangsheng Pharmaceutical Co Ltd
CNY | |
Free Cash Flow | CNY |
Earnings Waterfall
Hunan Fangsheng Pharmaceutical Co Ltd
Revenue
|
1.8B
CNY
|
Cost of Revenue
|
-541.1m
CNY
|
Gross Profit
|
1.2B
CNY
|
Operating Expenses
|
-970.2m
CNY
|
Operating Income
|
250.3m
CNY
|
Other Expenses
|
22.7m
CNY
|
Net Income
|
273m
CNY
|
Profitability Score
Profitability Due Diligence
Hunan Fangsheng Pharmaceutical Co Ltd's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

Score
Hunan Fangsheng Pharmaceutical Co Ltd's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Hunan Fangsheng Pharmaceutical Co Ltd's solvency score is 52/100. The higher the solvency score, the more solvent the company is.

Score
Hunan Fangsheng Pharmaceutical Co Ltd's solvency score is 52/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Hunan Fangsheng Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for
Hunan Fangsheng Pharmaceutical Co Ltd
is 14.71 CNY
with a low forecast of 14.13 CNY and a high forecast of 15.59 CNY.
Dividends
Current shareholder yield for Hunan Fangsheng Pharmaceutical Co Ltd is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
Hunan Fangsheng Pharmaceutical Co Ltd
stock under the Base Case scenario is
14.9
CNY.
Compared to the current market price of 10.19 CNY,
Hunan Fangsheng Pharmaceutical Co Ltd
is
Undervalued by 32%.